摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-(4-fluorophenyl)-N-methylthiazol-2-amine | 110989-69-0

中文名称
——
中文别名
——
英文名称
4-(4-fluorophenyl)-N-methylthiazol-2-amine
英文别名
N-methyl-4-p-fluorophenylthiazole-2-amine;4-(4-fluorophenyl)-2-methylaminothiazole;4-(4-fluorophenyl)-N-methyl-1,3-thiazol-2-amine
4-(4-fluorophenyl)-N-methylthiazol-2-amine化学式
CAS
110989-69-0
化学式
C10H9FN2S
mdl
MFCD08233031
分子量
208.259
InChiKey
MVAWFZOBAJJRCS-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    136-137 °C
  • 沸点:
    329.4±34.0 °C(Predicted)
  • 密度:
    1.292±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3
  • 重原子数:
    14
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.1
  • 拓扑面积:
    53.2
  • 氢给体数:
    1
  • 氢受体数:
    4

反应信息

  • 作为反应物:
    描述:
    4-(4-fluorophenyl)-N-methylthiazol-2-amine三氟乙酸酐甲苯 为溶剂, 反应 24.0h, 生成 4-(4-fluorophenyl)-2-(N-methyl)trifluoroacetamidothiazole
    参考文献:
    名称:
    Bramley, (Miss) Susan E.; Dupplin, Viscount; Goberdhan, Dhanesh G. C., Journal of the Chemical Society. Perkin transactions I, 1987, p. 639 - 644
    摘要:
    DOI:
  • 作为产物:
    描述:
    4-氟苯乙烯1,3-二溴-5,5-二甲基海因 作用下, 以 乙醇 为溶剂, 反应 3.0h, 生成 4-(4-fluorophenyl)-N-methylthiazol-2-amine
    参考文献:
    名称:
    由1,3-二溴-5,5-二甲基乙内酰脲(DBH)介导的苯乙烯衍生物合成2-氨基噻唑
    摘要:
    据报道,通过DBH介导的苯乙烯和硫脲的氧化环化合成2-氨基噻唑的有效方法。使用DBH作为溴源和氧化剂,通过两步一锅法成功地将各种烯烃成功转化为相应的2-氨基噻唑,产率为10-81%。该方法可以容易地以克为单位进行,并且成功地用于以苯乙烯为起始原料的抗炎药fanetizole的合成。
    DOI:
    10.1016/j.tet.2018.05.021
点击查看最新优质反应信息

文献信息

  • Small Molecule Library Synthesis Using Segmented Flow
    作者:Christina M. Thompson、Jennifer L. Poole、Jeffrey L. Cross、Irini Akritopoulou-Zanze、Stevan W. Djuric
    DOI:10.3390/molecules16119161
    日期:——
    Flow chemistry has gained considerable recognition as a simple, efficient, and safe technology for the synthesis of many types of organic and inorganic molecules ranging in scope from large complex natural products to silicon nanoparticles. In this paper we describe a method that adapts flow chemistry to the synthesis of libraries of compounds using a fluorous immiscible solvent as a spacer between reactions. The methodology was validated in the synthesis of two small heterocycle containing libraries. The reactions were performed on a 0.2 mmol scale, enabling tens of milligrams of material to be generated in a single 200 mL reaction plug. The methodology allowed library synthesis in half the time of conventional microwave synthesis while maintaining similar yields. The ability to perform multiple, potentially unrelated reactions in a single run is ideal for making small quantities of many different compounds quickly and efficiently.
    流动化学作为一种简便、高效且安全的合成技术,已获得广泛认可,适用于多种有机和无机分子的制备,其规模从复杂的大型天然产物到硅纳米颗粒不等。本文介绍了一种利用流动化学合成化合物库的方法,该方法采用氟烃不溶性溶剂作为反应间的间隔物。我们在合成两个含小杂环的化合物库中验证了该方法。反应规模为0.2毫摩尔,单次200毫升反应插件即可生成数十毫克的物质。与传统微波合成相比,该方法在保持相似产率的同时,将化合物库合成时间缩短了一半。能够在单次运行中进行多个潜在不相关的反应,这为快速高效地制备少量多种不同化合物提供了理想条件。
  • CuBr<sub>2</sub> mediated synthesis of 2-Aminothiazoles from dithiocarbamic acid salts and ketones
    作者:Baohua Zhang、Lanxiang Shi
    DOI:10.1080/10426507.2019.1633316
    日期:2019.12.2
    Abstract In a one-pot procedure, CuBr2 has been used as a efficient desulfurizing agent in the synthesis of 2-aminothiazoles by the condensation of in situ-generated 1-substituted thioureas from their dithiocarbamic acid salts, with in situ-generated α-bromoketones from ketones. All reactions were carried out under optimized reaction conditions and gave the target products in 61–95% yield.
    摘要 在一锅法中,CuBr2 已被用作一种有效的脱硫剂,用于通过原位生成的二硫代氨基甲酸盐的 1-取代硫脲与原位生成的 α-溴酮缩合合成 2-氨基噻唑。从酮。所有反应均在优化的反应条件下进行,目标产物的产率为 61-95%。
  • [EN] NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF INFLAMMATORY DISORDERS<br/>[FR] NOUVEAUX COMPOSÉS ET COMPOSITIONS PHARMACEUTIQUES LES COMPRENANT POUR LE TRAITEMENT DE TROUBLES INFLAMMATOIRES
    申请人:GALAPAGOS NV
    公开号:WO2014202458A1
    公开(公告)日:2014-12-24
    The present invention discloses compounds according to Formula I: Wherein R 1a, R 1b, R 2, R 4, R5, R 6, R 7, R 8, W, X, Y, Z, Cy, and the subscript a are as defined herein. The present invention relates to compounds inhibiting autotaxin (NPP2 or ENPP2), methods for their production, pharmaceutical compositions comprising the same, and methods of treatment using the same, for the prophylaxis and/or treatment of diseases involving fibrotic diseases,proliferative diseases, inflammatory diseases, autoimmune diseases, respiratory diseases, cardiovascular diseases, neurodegenerative diseases, dermatological disorders, and/or abnormal angiogenesis associated diseases by administering the compound of the invention.
    本发明公开了根据式I的化合物:其中R 1a、R 1b、R 2、R 4、R5、R 6、R 7、R 8、W、X、Y、Z、Cy和下标a如本文所定义。本发明涉及抑制自体脂肪酶(NPP2或ENPP2)的化合物,其制备方法,包含其的药物组合物,以及使用该化合物进行预防和/或治疗涉及纤维化疾病、增殖性疾病、炎症性疾病、自身免疫疾病、呼吸系统疾病、心血管疾病、神经退行性疾病、皮肤病和/或与异常血管生成相关疾病的方法。
  • [EN] COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF INFLAMMATORY DISORDERS<br/>[FR] COMPOSÉS ET COMPOSITIONS PHARMACEUTIQUES LES CONTENANT DESTINÉS À TRAITER LES TROUBLES INFLAMMATOIRES
    申请人:GALAPAGOS NV
    公开号:WO2014139882A1
    公开(公告)日:2014-09-18
    The present invention discloses compounds according to Formula I: Wherein R1a, R1b, R2, R4, R5, R6a, R6b, R7, R8, W, X, Cy, and the subscript a are as defined herein. The present invention relates to compounds inhibiting autotaxin (NPP2 or ENPP2), methods for their production, pharmaceutical compositions comprising the same, and methods of treatment using the same, for the prophylaxis and/or treatment of diseases involving fibrotic diseases, proliferative diseases, inflammatory diseases, autoimmune diseases, respiratory diseases, cardiovascular diseases, neurodegenerative diseases, dermatological disorders, and/or abnormal angiogenesis associated diseasesby administering the compound of the invention.
    本发明公开了根据式I的化合物:其中R1a、R1b、R2、R4、R5、R6a、R6b、R7、R8、W、X、Cy和下标a如本文所定义。本发明涉及抑制自体脂肪酶(NPP2或ENPP2)的化合物,其制备方法,包含其的药物组合物,以及使用该化合物进行预防和/或治疗涉及纤维化疾病、增生性疾病、炎症性疾病、自身免疫疾病、呼吸系统疾病、心血管疾病、神经退行性疾病、皮肤病和/或与异常血管生成相关疾病的方法。
  • Catalyst-free efficient synthesis of 2-aminothiazoles in water at ambient temperature
    作者:Taterao M. Potewar、Sachin A. Ingale、Kumar V. Srinivasan
    DOI:10.1016/j.tet.2008.03.082
    日期:2008.5
    A highly efficient and facile method has been described for the synthesis of substituted 2-aminothiazoles in water without any added catalyst or co-organic solvent. The reaction was carried out at ambient temperature and the products were obtained in excellent isolated yields. The developed protocol is successfully applied for the preparation of an anti-inflammatory drug, fanetizole.
    已经描述了一种在不添加任何催化剂或共有机溶剂的情况下在水中合成取代的2-氨基噻唑的高效且简便的方法。该反应在环境温度下进行,并且产物以优异的分离产率得到。所开发的方案已成功应用于抗炎药Fanetizole的制备。
查看更多

同类化合物

伊莫拉明 (5aS,6R,9S,9aR)-5a,6,7,8,9,9a-六氢-6,11,11-三甲基-2-(2,3,4,5,6-五氟苯基)-6,9-甲基-4H-[1,2,4]三唑[3,4-c][1,4]苯并恶嗪四氟硼酸酯 (5-氨基-1,3,4-噻二唑-2-基)甲醇 齐墩果-2,12-二烯[2,3-d]异恶唑-28-酸 黄曲霉毒素H1 高效液相卡套柱 非昔硝唑 非布索坦杂质Z19 非布索坦杂质T 非布索坦杂质K 非布索坦杂质E 非布索坦杂质67 非布索坦杂质65 非布索坦杂质64 非布索坦杂质61 非布索坦代谢物67M-4 非布索坦代谢物67M-2 非布索坦代谢物 67M-1 非布索坦-D9 非布索坦 非唑拉明 雷西纳德杂质H 雷西纳德 阿西司特 阿莫奈韦 阿米苯唑 阿米特罗13C2,15N2 阿瑞匹坦杂质 阿格列扎 阿扎司特 阿尔吡登 阿塔鲁伦中间体 阿培利司N-1 阿哌沙班杂质26 阿哌沙班杂质15 阿可替尼 阿作莫兰 阿佐塞米 镁(2+)(Z)-4'-羟基-3'-甲氧基肉桂酸酯 锌1,2-二甲基咪唑二氯化物 铵2-(4-氯苯基)苯并恶唑-5-丙酸盐 铬酸钠[-氯-3-[(5-二氢-3-甲基-5-氧代-1-苯基-1H-吡唑-4-基)偶氮]-2-羟基苯磺酸基][4-[(3,5-二氯-2-羟基苯 铁(2+)乙二酸酯-3-甲氧基苯胺(1:1:2) 钠5-苯基-4,5-二氢吡唑-1-羧酸酯 钠3-[2-(2-壬基-4,5-二氢-1H-咪唑-1-基)乙氧基]丙酸酯 钠3-(2H-苯并三唑-2-基)-5-仲-丁基-4-羟基苯磺酸酯 钠(2R,4aR,6R,7R,7aS)-6-(2-溴-9-氧代-6-苯基-4,9-二氢-3H-咪唑并[1,2-a]嘌呤-3-基)-7-羟基四氢-4H-呋喃并[3,2-D][1,3,2]二氧杂环己膦烷e-2-硫醇2-氧化物 野麦枯 野燕枯 醋甲唑胺